137 related articles for article (PubMed ID: 38290689)
1. Pulmonary RNA interference against acute lung injury mediated by mucus- and cell-penetrating nanocomplexes.
Zhang W; Shen J; Liang J; Ge C; Zhou Y; Yin L; Ji Y
Acta Biomater; 2024 Mar; 177():332-346. PubMed ID: 38290689
[TBL] [Abstract][Full Text] [Related]
2. Macrophage-targeting and reactive oxygen species (ROS)-responsive nanopolyplexes mediate anti-inflammatory siRNA delivery against acute liver failure (ALF).
Zhang W; Zhou Y; Li X; Xu X; Chen Y; Zhu R; Yin L
Biomater Sci; 2018 Jun; 6(7):1986-1993. PubMed ID: 29855002
[TBL] [Abstract][Full Text] [Related]
3. Fluorinated α-Helical Polypeptides Synchronize Mucus Permeation and Cell Penetration toward Highly Efficient Pulmonary siRNA Delivery against Acute Lung Injury.
Ge C; Yang J; Duan S; Liu Y; Meng F; Yin L
Nano Lett; 2020 Mar; 20(3):1738-1746. PubMed ID: 32039603
[TBL] [Abstract][Full Text] [Related]
4. Surface Coating of Pulmonary siRNA Delivery Vectors Enabling Mucus Penetration, Cell Targeting, and Intracellular Radical Scavenging for Enhanced Acute Lung Injury Therapy.
Zhu J; Guo M; Cui Y; Meng Y; Ding J; Zeng W; Zhou W
ACS Appl Mater Interfaces; 2022 Feb; 14(4):5090-5100. PubMed ID: 35060376
[TBL] [Abstract][Full Text] [Related]
5. Macrophage Membrane-Reversibly Cloaked Nanotherapeutics for the Anti-Inflammatory and Antioxidant Treatment of Rheumatoid Arthritis.
Shan B; Zhou Y; Yin M; Deng Y; Ge C; Liu Z; Zhou R; Dong Q; Zhou X; Yin L
Small Methods; 2023 Sep; 7(9):e2300667. PubMed ID: 37469217
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Hepatic Inflammation via Systemic siRNA Delivery by Membrane-Disruptive and Endosomolytic Helical Polypeptide Hybrid Nanoparticles.
He H; Zheng N; Song Z; Kim KH; Yao C; Zhang R; Zhang C; Huang Y; Uckun FM; Cheng J; Zhang Y; Yin L
ACS Nano; 2016 Feb; 10(2):1859-70. PubMed ID: 26811880
[TBL] [Abstract][Full Text] [Related]
7. Pillar arene Se nanozyme therapeutic systems with dual drive power effectively penetrated mucus layer combined therapy acute lung injury.
Chen X; Yang Y; Mai Q; Ye G; Liu Y; Liu J
Biomaterials; 2024 Jan; 304():122384. PubMed ID: 38016334
[TBL] [Abstract][Full Text] [Related]
8. Self-assisted membrane-penetrating helical polypeptides mediate anti-inflammatory RNAi against myocardial ischemic reperfusion (IR) injury.
Liang Q; Li F; Li Y; Liu Y; Lan M; Wu S; Wu X; Ji Y; Zhang R; Yin L
Biomater Sci; 2019 Aug; 7(9):3717-3728. PubMed ID: 31187803
[TBL] [Abstract][Full Text] [Related]
9. Anti-Inflammatory Effect of Anti-TNF-α SiRNA Cationic Phosphorus Dendrimer Nanocomplexes Administered Intranasally in a Murine Acute Lung Injury Model.
Bohr A; Tsapis N; Andreana I; Chamarat A; Foged C; Delomenie C; Noiray M; El Brahmi N; Majoral JP; Mignani S; Fattal E
Biomacromolecules; 2017 Aug; 18(8):2379-2388. PubMed ID: 28639789
[TBL] [Abstract][Full Text] [Related]
10. Zn-dipicolylamine-based reactive oxygen species-responsive lipids for siRNA delivery and in vivo colitis treatment.
Guo Y; He X; Zhao RM; Yang HZ; Huang Z; Zhang J; Yu XQ
Acta Biomater; 2022 Jul; 147():287-298. PubMed ID: 35489607
[TBL] [Abstract][Full Text] [Related]
11. [Blockade of programmed death-ligand 1 attenuates indirect acute lung injury in mice through targeting endothelial cells but not epithelial cells].
Sun B; Li X; Zheng G; Dong T; Li Y; Li H; Yan Y; Bai J; Xu S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jan; 31(1):37-43. PubMed ID: 30707867
[TBL] [Abstract][Full Text] [Related]
12. Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery.
Baldassi D; Ngo TMH; Merkel OM
Pharm Res; 2024 Jan; 41(1):77-91. PubMed ID: 36447020
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.
Zoulikha M; Xiao Q; Boafo GF; Sallam MA; Chen Z; He W
Acta Pharm Sin B; 2022 Feb; 12(2):600-620. PubMed ID: 34401226
[TBL] [Abstract][Full Text] [Related]
14. Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy.
Merckx P; De Backer L; Van Hoecke L; Guagliardo R; Echaide M; Baatsen P; Olmeda B; Saelens X; Pérez-Gil J; De Smedt SC; Raemdonck K
Acta Biomater; 2018 Sep; 78():236-246. PubMed ID: 30118853
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal Macrophage-Specific TNF-α Gene Silencing in LPS-Induced Acute Inflammation Model Using CD44 Targeting Hyaluronic Acid Nanoparticles.
Kosovrasti VY; Nechev LV; Amiji MM
Mol Pharm; 2016 Oct; 13(10):3404-3416. PubMed ID: 27552547
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute lung injury and early- and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes.
Wang Y; Ding L; Li Z; Chen G; Sun M; Oupicky D
J Control Release; 2019 Nov; 314():12-24. PubMed ID: 31644934
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model.
Bohr A; Tsapis N; Foged C; Andreana I; Yang M; Fattal E
Eur J Pharm Biopharm; 2020 Nov; 156():114-120. PubMed ID: 32798665
[TBL] [Abstract][Full Text] [Related]
18. Optimization of multifunctional chitosan-siRNA nanoparticles for oral delivery applications, targeting TNF-α silencing in rats.
He C; Yin L; Song Y; Tang C; Yin C
Acta Biomater; 2015 Apr; 17():98-106. PubMed ID: 25662912
[TBL] [Abstract][Full Text] [Related]
19. Silencing of Paralemmin-3 Protects Mice from lipopolysaccharide-induced acute lung injury.
Li S; Guo L; Zhao Y; Qian P; Lv X; Qian L; Wang Q; Qian G; Yao W; Wu X
Peptides; 2016 Feb; 76():65-72. PubMed ID: 26772416
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury.
Zhang Y; Liang D; Dong L; Ge X; Xu F; Chen W; Dai Y; Li H; Zou P; Yang S; Liang G
Respir Res; 2015 Mar; 16(1):43. PubMed ID: 25889862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
